Eczacıbaşı-Monrol announces its acquisition of Capintec, the world’s best-known brand in radiation measurement and protection equipment for nuclear medicine
Building on its strong performance in Turkey and neighboring countries where it has established modern production facilities, Eczacıbaşı-Monrol Nuclear Products has taken a major step towards its target of global growth by reaching an agreement to acquire Capintec, the world’s best known brand in the field of radiation measurement and protection products for nuclear medicine.
Capintec has provided state-of-the-art instrumentation to customers around the world for 45 years. Its innovative solutions have contributed significantly not only to nuclear medicine but also oncology, endocrinology, diagnostic radiology and radiation therapy. Capintec’s headquarters are located in Ramsey, New Jersey, and its production plant in Pittsburgh, Pennsylvania.
In a related statement to the press, Dr. Erdal Karamercan, Chairman of the Board of Eczacıbaşı-Monrol and President and CEO of the Eczacıbaşı Group, noted that Eczacıbaşı-Monrol took its first step towards strengthening its innovative capacity and growth potential in August 2011, when it acquired Mol-Image. “This acquisition of Capintec, the world’s best-known brand in its field,” he said, “builds on the momentum started with Mol-Image, which develops and produces new equipment for nuclear medicine, chemicals, radiopharmaceuticals, and radiation protection products, and represents a major advance in the achievement of our strategic global targets.”
Explaining that the advanced technology products currently produced by Mol-Image to FDA norms as well as related technical infrastructure and know-how would be transferred from Mol-Image to Capintec, Karamercan added, “Drawing on the synergy created by this acquisition, we will market innovative instruments and equipment developed by Capintec and Mol-Image through Eczacıbaşı-Monrol’s extensive sales and distribution channels to reach customers in Turkey, Europe and many other markets around the world.”
To indicate the tremendous synergy created by the acquisition, Şükrü Bozluolçay, Vice Chairman of Eczacıbaşı-Monrol and Chairman of the Bozlu Group, noted that Capintec would enable Eczacıbaşı-Monrol to launch its products on the American continent as well expand its portfolio in Europe, where it is projected there will be three production facilities and sales of EU GMP certified products in five countries by 2013.
Eczacıbaşı-Monrol Nuclear Products manufactures high quality radiopharmaceuticals for diagnosis and treatment at world-class production centers using advanced and environmentally sensitive technology.
Through continual investments in new technologies and production techniques, Eczacıbaşı-Monrol ensures that its products and services are of the highest quality, meet the strictest safety standards, and comply with the latest national and international guidelines.
Eczacıbaşı-Monrol has seven production facilities in Turkey, Gebze (headquarters), Ankara, Adana, Izmir, Istanbul, Antalya and Malatya, and four plants abroad: Romania, Egypt, Kuwait and Dubai. With the opening of new plants in Bulgaria, Jordan and Poland in 2013, it will have 14 plants in all.
One of the world’s leading suppliers of energy measurement products and services, Capintec is dedicated to continually developing devices, instrumentation and services utilizing the most advanced technology available in its industry.
As the world’s best-known brand in the development, manufacturing and marketing of state-of-the-art radiation measuring, monitoring and radiation protection instrumentation for more than 45 years, Capintec supplies thousands of products as well as new and innovative solutions for radiation measurement applications to customers around the world.
Capintec’s sales and administrative headquarters are located in Ramsey, New Jersey; its production facility is in Pittsburgh, Pennsylvania.